Glycopyrronium

Back to search
Scientific Name: Glycopyrronium
Brand Name: Bevespi, Breztri, Cuvposa, Dartisla, Enurev Breezhaler, Glycate, Glyrx, Lonhala, Qbrexza, Robinul, Robinul Forte, Seebri Breezhaler, Sialanar, Tovanor Breezhaler, Ultibro
Company Owner: Abraxis pharmaceutical products, Hospira inc, Luitpold pharmaceuticals inc, Teva parenteral medicines inc, Watson laboratories inc, Baxter healthcare corp anesthesia and critical care, Ah robins co, Shionogi pharma inc, Corepharma llc, Dr reddys laboratories ltd, Par pharmaceutical inc, Ranbaxy inc, Vintage pharmaceuticals llc, West ward pharmaceutical corp
Mechanism Of Action Glycopyrronium is a muscarinic antagonist with the highest affinity for M1 receptors, followed by M3, M2/M4, and M5.
Description of the Drug: Glycopyrronium is an anticholinergic agent used to treat hyperhidrosis, severe drooling, COPD, used with other medications to treat ulcers, and used in anesthesia.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00986